Dear Reader,
We have identified several healthtech stocks which are expected to go “Ex-Dividend” starting Thursday, July 12th.
If you purchase a stock on its ex-dividend date or after, you will not receive the next dividend payment.
Instead, the seller gets the dividend. If you purchase before the ex-dividend date, you get the dividend.
If you sell your stock before the ex-dividend date, you also are selling away your right to the stock dividend.
So please keep this in mind.
Below is our latest Dividend Report:
Encompass Health
Symbol: EHC
Recent EHC Stock Price: $48.41
Average Analyst Price Target: $76.55 (58.13%)
EHC Market Cap: $4.83B
Expected Ex-Dividend Date for EHC stock: Jul 12 2022
Expected Payment Date for EHC stock: Jul 20 2022
Expected Dividend & Yield for EHC stock: 2.31%
Recent Analyst Action: Kevin Fischbeck, analyst at Bank of America Securities, reiterates coverage on Encompass Health (EHC) stock in the Healthcare sector with a Buy rating and a price target of $ 52 (1 week ago).
TipRanks.com also reports that Encompass Health stock currently has 11 analysts offering 12-month price targets and the consensus is a Strong Buy rating with an average price target is $76.55 . The target pricing ranges from a high forecast of $85.00 down to a low forecast of $52.00. Encompass Health (EHC)’s last closing stock price was $48.41 which would put the average price target at 58.13% upside.Here are 3rd party ratings for EHC stock:
- TipRanks.com: Strong Buy
- TradingView.com: Neutral
- Yahoo! Finance: Bullish Short-Term Outlook
- Barchart.com: Strong sell
- Zacks.com: Strong Sell, Bottom 37% (158 out of 251)
--------------------------------------------------------------------------
Abbott Labs
Symbol: ABT
Recent ABT Stock Price: $109.26
Average Analyst Price Target: $131.10 (19.99%)
ABT Market Cap: $191.31B
Expected Ex-Dividend Date for ABT stock: Jul 14 2022
Expected Payment Date for ABT stock: Aug 15 2022
Expected Dividend & Yield for ABT stock: 1.68%
Recent Analyst Action: Michael Polark, analyst at Wolfe Research, reiterates coverage on Abbott Labs (ABT) stock in the Healthcare sector with a Sell rating and a price target of $ 95 (5 days ago).
TipRanks.com also reports that Abbott Labs stock currently has 10 analysts offering 12-month price targets and the consensus is a Moderate Buy rating with an average price target is $131.10 . The target pricing ranges from a high forecast of $145.00 down to a low forecast of $95.00. Abbott Labs (ABT)’s last closing stock price was $109.26 which would put the average price target at 19.99% upside.Here are 3rd party ratings for ABT stock:
- TipRanks.com: Moderate Buy
- TradingView.com: Sell
- Yahoo! Finance: Bullish Short-Term Outlook
- Barchart.com: Strong sell
- Zacks.com: Hold, Bottom 35% (164 out of 251)
--------------------------------------------------------------------------
And there you have it...
Keep in mind, if you purchase a stock on its ex-dividend date or after, you will not receive the next dividend payment.
Instead, the seller gets the dividend. If you purchase before the ex-dividend date, you get the dividend.
If you sell your stock before the ex-dividend date, you also are selling away your right to the stock dividend.
If you have questions about specific dividends, you should consult with your financial advisor or visit Investor.gov for more information.
Sincerely,
The Editor, HealthTechMovers.com
HealthTechMovers.com (HTM) is built for investors who are interested in healthcare stocks, health insurance stocks, healthcare technology stocks, biotechnology stocks, pharmaceutical stocks, healthcare service provider stocks, life science stocks and more. HTM aggregates market data from top tier financial content providers like Barchart.com, Tipranks.com, TradingView.com, Yahoo! Finance, and Zacks.com. The research and editorial team behind HTM consolidates this aggregated data into easily consumable reports used to produce articles, newsletters, and web content. The reports produced by HTM contain timely information stock analysis, stock price targets, earnings announcements, insider trades, dividends, and top moving stocks.
